For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Voyager Therapeutics, Inc.

USPTO Granted Patents = 41

CIPO Patents = 5

EPO Patents = 4

Trademarks = 11

Forward Citations = 120

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Jinzhao Hou (19 out of 21 patents)

Dinah Wen-Yee Sah (16 out of 38 patents)

Mathieu E Nonnenmacher (15 out of 15 patents)

4. Pengcheng Zhou (9 out of 9 patents)

5. Robert Michael Kotin (8 out of 22 patents)

6. Adrian P Kells (6 out of 12 patents)

7. Markus Hossbach (6 out of 20 patents)

8. Jochen Deckert (6 out of 8 patents)

9. Holger Patzke (6 out of 6 patents)

10. Bernard Ravina (5 out of 5 patents)

11. Qingmin Chen (4 out of 11 patents)

12. Martin Goulet (4 out of 4 patents)

13. Sylvain Cecchini (3 out of 3 patents)

14. James McLaughlin (3 out of 6 patents)

15. Todd Carter (3 out of 3 patents)

41 patents: Sort by Forward Citations

1. 12419969 - AAV capsid variants and uses thereof (2025-09-23),

2. 12319929 - Compositions and methods for the treatment of Parkinson's disease (2025-06-03),

3. 12305189 - Compositions and methods for delivery of AAV (2025-05-20),

4. 12296025 - AAV capsid variants and uses thereof (2025-05-13),

5. 12291565 - Tau binding compounds (2025-05-06),

6. 12281321 - Frataxin expression constructs having engineered promoters and methods of use thereof (2025-04-21),

7. 12252703 - Closed-ended linear duplex DNA for non-viral gene transfer (2025-03-18),

8. 12180500 - Chimeric capsids (2024-12-31),

9. 12146150 - Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery (2024-11-19),

10. 12129476 - Methods for measuring the potency of AADC viral vectors (2024-10-29),

11. 12123002 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS) (2024-10-22),

12. 12116589 - Treatment of amyotrophic lateral sclerosis (ALS) (2024-10-15),

13. 12084659 - Modulatory polynucleotides (2024-09-10),

14. 12071625 - Modulatory polynucleotides (2024-08-27),

15. 12060567 - Engineered untranslated regions (UTR) for AAV production (2024-08-13),

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases. They are focused on discovering and developing innovative therapies that can provide significant improvements to patients' lives. Leveraging their deep expertise in neuroscience, they work towards addressing diseases such as Parkinson's disease, Huntington's disease, and other severe neurological disorders. Voyager Therapeutics is committed to advancing gene therapy as a potential option for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

41 Patents

#55 in Cambridge, MA

#476 in Massachusetts

#8,156 in US

#16,191 in the World

Cambridge, MA, United States of America

Voyager Therapeutics, Inc.

Forward Citations = 120

56 inventors:

Jinzhao Hou (19 out of 21 patents)

Dinah Wen-Yee Sah (16 out of 38 patents)

Mathieu E Nonnenmacher (15 out of 15 patents)

4. Pengcheng Zhou (9 out of 9 patents)

5. Robert Michael Kotin (8 out of 22 patents)

Please report any incorrect information to support@idiyas.com

Loading…